Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-042402
Filing Date
2014-06-18
Accepted
2014-06-18 17:21:06
Documents
2
Period of Report
2014-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3357
2 EX-24 DOCUMENT attachment1.htm EX-24 5078
  Complete submission text file 0001209191-14-042402.txt   9832
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Issuer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARDELYX, INC. 34175 ARDENWOOD BLVD, SUITE 100 FREMONT CA 94555
Business Address
Charmot Dominique (Reporting) CIK: 0001611185 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36485 | Film No.: 14928802